基本信息
浏览量:107
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Research:
Dr. Tait's research focuses primarily on two areas: the annexin family of calcium-dependent phospholipid binding proteins, and clinical molecular-genetic testing. In the first area, the long-range goal is to understand the mechanism of annexin-membrane binding, and to develop better means to diagnose and treat disorders related to thrombosis and apoptosis. The interaction of annexin V with phospholipids, platelets, leukocytes, and erythrocytes has been characterized quantitatively. These results show that annexin V is an excellent probe for detection and functional inhibition of cellular procoagulant phospholipid (primarily phosphatidylserine). The structural requirements for membrane binding have been defined, and annexin V has been developed as a means to image apoptotic cells in vivo in clinical areas such as organ transplant rejection and cancer chemotherapy. In the second area, novel molecular-genetic clinical assays have been developed for the diagnosis and management of genetic and neoplastic diseases, and their analytical and clinical performance has been evaluated in the clinical laboratory setting.
Dr. Tait's research focuses primarily on two areas: the annexin family of calcium-dependent phospholipid binding proteins, and clinical molecular-genetic testing. In the first area, the long-range goal is to understand the mechanism of annexin-membrane binding, and to develop better means to diagnose and treat disorders related to thrombosis and apoptosis. The interaction of annexin V with phospholipids, platelets, leukocytes, and erythrocytes has been characterized quantitatively. These results show that annexin V is an excellent probe for detection and functional inhibition of cellular procoagulant phospholipid (primarily phosphatidylserine). The structural requirements for membrane binding have been defined, and annexin V has been developed as a means to image apoptotic cells in vivo in clinical areas such as organ transplant rejection and cancer chemotherapy. In the second area, novel molecular-genetic clinical assays have been developed for the diagnosis and management of genetic and neoplastic diseases, and their analytical and clinical performance has been evaluated in the clinical laboratory setting.
研究兴趣
论文共 107 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Leather M. Byers,Angela Jacobson, Andrew S. Mcfaddin,Cigdem H. Ussakli,Anna Newlin,Peter P. Stanich, Stephanie More, Amanda Hamblett,Jonathan E. Tait,Brian Shirts,Colin C. Pritchard,Eric Q. Konnick,
JCO PRECISION ONCOLOGYno. 2 (2018): 1-7
Brian H. Shirts,Silvia Casadei,Angela L. Jacobson,Ming K. Lee,Suleyman Gulsuner,Robin L. Bennett, Margaret Miller, Sarah A. Hall,Heather Hampel,Fuki M. Hisama, Lorraine V. Naylor, Cathleen Goetsch,
引用0浏览0引用
0
0
引用40浏览0WOS引用
40
0
American Journal of Clinical Pathologyno. 5 (2014): 710-710
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn